medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2018, Número 4

<< Anterior Siguiente >>

Rev Invest Clin 2018; 70 (4)


Prediction of Molecular Signature, Potential Biomarkers, and Molecular Pathways Associated with Membranous Nephropathy Based on Protein-Protein Interactions

Taherkhani A, Kalantari S, Nafar M

Idioma: Ingles.
Referencias bibliográficas: 43
Paginas: 184-191
Archivo PDF: 320.55 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Cattran DC. Idiopathic membranous glomerulonephritis. Kidney Int. 2001;59:1983-94.

  2. Kubota K, Hoshino J, Ueno T, et al. Phospholipase A2 receptorpositive idiopathic membranous glomerulonephritis with onset at 95 years: case report. Case Rep Nephrol Dial. 2016;6:76-82.

  3. Santos FR. Membranous glomerulonephritis: new insights in pathophysiology and therapeutic approach. J Bras Nefrol. 2014; 36:59-62.

  4. Huang YM, Zhou HR, Zhang L, et al. Spontaneous remission of membranous glomerulonephritis with successful fetal outcome: a case report and literature review. Medicine (Baltimore). 2016; 95:e4022.

  5. Beck LH Jr., Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361:11-21.

  6. Debiec H, Guigonis V, Mougenot B, et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med. 2002;346:2053-60.

  7. Roccatello D, Sciascia S, Di Simone D, et al. New insights into immune mechanisms underlying response to rituximab in patients with membranous nephropathy: a prospective study and a review of the literature. Autoimmun Rev. 2016;15:529-38.

  8. Kalantari S, Nafar M. A comprehensive narrative review of diagnostic biomarkers in human primary membranous nephropathy. Biomark Med. 2017. DOI: 10.2217/bmm-2017-0081.

  9. Abedi M, Gheisari Y. Nodes with high centrality in protein interaction networks are responsible for driving signaling pathways in diabetic nephropathy. Peer J. 2015;3:e1284.

  10. Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498-504.

  11. Bader GD, Hogue CW. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinformatics. 2003;4:2.

  12. Bindea G, Mlecnik B, Hackl H, et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009;25:1091-3.

  13. Janky R, Verfaillie A, Imrichová H, et al. IRegulon: from a gene list to a gene regulatory network using large motif and track collections. PLoS Comput Biol. 2014;10:e1003731.

  14. Janky R, Binda MM, Allemeersch J, et al. Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma. BMC Cancer. 2016;16:632.

  15. Hauser PV, Perco P, Mühlberger I, et al. Microarray and bioinformatics analysis of gene expression in experimental membranous nephropathy. Nephron Exp Nephrol. 2009;112:e43-58.

  16. Chonchol M, Cigolini M, Targher G. Association between 25-hydroxyvitamin D deficiency and cardiovascular disease in type 2 diabetic patients with mild kidney dysfunction. Nephrol Dial Transplant. 2008;23:269-74.

  17. MacDonald PN, Sherman DR, Dowd DR, Jefcoat SC Jr. DeLisle RK. The vitamin D receptor interacts with general transcription factor IIB. J Biol Chem. 1995;270:4748-52.

  18. Lips P. Vitamin D physiology. Prog Biophys Mol Biol. 2006;92:4-8.

  19. Brown AJ. Mechanisms for the selective actions of vitamin D analogues. Curr Pharm Des. 2000;6:701-16.

  20. Xiong M, Gong J, Liu Y, Xiang R, Tan X. Loss of vitamin D receptor in chronic kidney disease: a potential mechanism linking inflammation to epithelial-to-mesenchymal transition. Am J Physiol Renal Physiol. 2012;303:F1107-15.

  21. Metzger D, Chambon P. Contribution of targeted conditional somatic mutagenesis to deciphering retinoid X receptor functions and to generating mouse models of human diseases. In: Conditional Mutagenesis: an Approach to Disease Models. Heidelberg, Berlin: Springer; 2007. p. 511-24.

  22. Grzegorzewska AE, Ostromecki G, Zielinska P, et al. Association of retinoid X receptor alpha gene polymorphism with clinical course of chronic glomerulonephritis. Med Sci Monit. 2015; 21:3671-81.

  23. Roszer T, Menéndez-Gutiérrez MP, Lefterova MI, et al. Autoimmune kidney disease and impaired engulfment of apoptotic cells in mice with macrophage peroxisome proliferator-activated receptor gamma or retinoid X receptor alpha deficiency. J Immunol. 2011;186:621-31.

  24. Wang B, Zuo K, Wu Y, et al. Correlation between B lymphocyte abnormality and disease activity in patients with idiopathic membranous nephropathy. J Int Med Res. 2011;39:86-95.

  25. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 1996;10:940-54.

  26. Hall JA, Cannons JL, Grainger JR, et al. Essential role for retinoic acid in the promotion of CD4(+) T cell effector responses via retinoic acid receptor alpha. Immunity. 2011;34:435-47.

  27. Hall JA, Grainger JR, Spencer SP, Belkaid Y. The role of retinoic acid in tolerance and immunity. Immunity. 2011;35:13-22.

  28. Masutani K, Taniguchi M, Nakashima H, et al. Up-regulated interleukin- 4 production by peripheral T-helper cells in idiopathic membranous nephropathy. Nephrol Dial Transplant. 2004;19:580-6.

  29. Kuroki A, Iyoda M, Shibata T, Sugisaki T. Th2 cytokines increase and stimulate B cells to produce igG4 in idiopathic membranous nephropathy. Kidney Int. 2005;68:302-10.

  30. Leonard EJ, Yoshimura T, Tanaka S, Raffeld M. Neutrophil recruitment by intradermally injected neutrophil attractant/activation protein-1. J Invest Dermatol. 1991;96:690-4.

  31. Swensson O, Schubert C, Christophers E, Schröder JM. Inflammatory properties of neutrophil-activating protein-1/interleukin 8 (NAP-1/IL-8) in human skin: a light- and electronmicroscopic study. J Invest Dermatol. 1991;96:682-9.

  32. Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol. 2001;2:108-15.

  33. Mackay CR. Chemokines: immunology’s high impact factors. Nat Immunol. 2001;2:95-101.

  34. Lionaki S, Siamopoulos K, Theodorou I, et al. Inhibition of tumour necrosis factor alpha in idiopathic membranous nephropathy: a pilot study. Nephrol Dial Transplant. 2009;24:2144-50.

  35. Niemir ZI, Stein H, Ciechanowicz A, et al. The in situ expression of interleukin-8 in the normal human kidney and in different morphological forms of glomerulonephritis. Am J Kidney Dis. 2004;43:983-98.

  36. Petrelli A, Gilestro GF, Lanzardo S, et al. The endophilin-CIN85- cbl complex mediates ligand-dependent downregulation of cmet. Nature. 2002;416:187-90.

  37. Boucrot E, Ferreira AP, Almeida-Souza L, et al. Endophilin marks and controls a clathrin-independent endocytic pathway. Nature. 2015;517:460-5.

  38. Song R, El-Dahr SS, Yosypiv IV. Receptor tyrosine kinases in kidney development. J Signal Transduct. 2011;2011:869281.

  39. Liu F, Zhuang S. Role of receptor tyrosine kinase signaling in renal fibrosis. Int J Mol Sci. 2016;17: pii: E972.

  40. Zhao B, Tumaneng K, Guan KL. The hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol. 2011;13:877-83.

  41. Seo E, Kim WY, Hur J, et al. The hippo-salvador signaling pathway regulates renal tubulointerstitial fibrosis. Sci Rep. 2016;6:31931.

  42. Liu Y, Carlsson R, Comabella M, et al. FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS. Nat Med. 2014;20:272-82.

  43. Behr R, Brestelli J, Fulmer JT, et al. Mild nephrogenic diabetes insipidus caused by foxa1 deficiency. J Biol Chem. 2004;279:41936-41.




2020     |     www.medigraphic.com